{"id":"NCT02103439","sponsor":"Biocad","briefTitle":"An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients","officialTitle":"Multicenter Open-label Randomized, Comparative Clinical Study to Evaluate Efficacy and Safety of Algeron (Cepeginterferon Alfa-2b, CJSC \"BIOCAD\", Russia) With Ribavirin Compared to PegIntron (Peginterferon Alfa-2b, Schering-Plough Labo N.V., Belgium) With Ribavirin in Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06-06","primaryCompletion":"2015-08-26","completion":"2015-08-26","firstPosted":"2014-04-03","resultsPosted":"2015-07-21","lastUpdate":"2018-08-09"},"enrollment":140,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis","Hepatitis C","Hepatitis C/ Human Immunodeficiency Virus Coinfection"],"interventions":[{"type":"DRUG","name":"Algeron","otherNames":["Cepeginterferon alfa-2b"]},{"type":"DRUG","name":"PegIntron","otherNames":["peginterferon alfa-2b"]}],"arms":[{"label":"Algeron","type":"EXPERIMENTAL"},{"label":"PegIntron","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to demonstrate the noninferiority of Algeron in combination with ribavirin compared to PegIntron in combination with ribavirin in treatment of chronic hepatitis C in Human Immunodeficiency Virus-1 infected patients","primaryOutcome":{"measure":"Early Virological Response","timeFrame":"12 weeks","effectByArm":[{"arm":"Algeron","deltaMin":90,"sd":null},{"arm":"PegIntron","deltaMin":81.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.227"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":23},"locations":{"siteCount":6,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":70},"commonTop":["Leucopenia","Anemia","Neutropenia","Lymphopenia","Flu-like syndrome"]}}